The Centers for Disease Control and Prevention (CDC) has confirmed that infection with Zika virus during pregnancy has been linked to serious birth defects. Ensuring access to effective contraception is integral to preventing harmful outcomes from Zika virus, and family planning providers across the country are joining in the prevention efforts. However, many providers experience persistent barriers to providing long-acting reversible contraceptive (LARC) methods due to their higher upfront costs in relation to other methods. These barriers inhibit providers’ ability to offer LARCs as an option for women seeking to delay pregnancy in the face of potential Zika infection.
NFPRHA’s membership call on Wednesday, June 29, at 2:00 p.m. ET, will discuss solutions to common barriers providers face related to offering LARC methods. Join NFPRHA’s Amanda Kimber to learn more about LARC stocking, billing, and reimbursement, as well as patient assistance programs available for LARC methods.
To join the webinar, please RSVP by completing the online registration form.